.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires inclusion of people with MASLD and size of liver outcomes in cardio-- renal-- metabolic tests, when data propose mechanistically possible advantages as well as professional safety-- as well as summarizes factors to consider for test design and also governing commendation.